Showing results 43 to 62 of 71
< previous
next >
| Issue Date | Title | Author(s) |
| 2015-01-01 | On resilience and acceptance in the transition to palliative care at the end of life | MacArtney, JI; Broom, A; Kirby, E; Good, P; Wootton, J; Yates, PM; Adams, J |
| 2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
| 2020-07-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Hardy, J; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Good, P |
| 2018-03-07 | Oral water soluble contrast for malignant bowel obstruction. | Syrmis, W; Richard, R; Jenkins-Marsh, S; Chia, SC; Good, P |
| 2022-09-13 | Pain management in advanced cancer: physical activity as an outcome - accelerometer feasibility study. | Lord, S; Good, P; Mielke, GI |
| 2019-07-01 | Palliative care in cirrhosis with decompensation | Plunkett, A; Mortimore, M; Good, P |
| 2019-01-02 | The pattern and timing of changes in preferred place of death for patients admitted to a community specialist palliative care service | Win, MM; Fischer, A; Good, P |
| 2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
| 2021-03 | Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. | Hardy, J; Haywood, A; Rickett, K; Sallnow, L; Good, P |
| 2020 | Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern? | Hardy, JR; Bundock, D; Cross, J; Gibbons, K; Pinkerton, R; Kindl, K; Good, P; Philip, J |
| 2019-12-01 | Quality use of medicines: Oral corticosteroids in advanced cancer | Pinkerton, E; Good, P; Kindl, K; Richard, R; Fischer, A; Hardy, JR |
| 2016 | Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. | George, R; Lobb, M; Haywood, A; Khan, S; Hardy, J; Good, P; Hennig, S; Norris, R |
| 2017-01 | Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward. | Ryan, J; Abbato, S; Greer, R; Vayne-Bossert, P; Good, P |
| 2020 | Regular dosing compared with as-needed dosing of opioids for management of chronic cancer pain: systematic review and meta-analysis. | Edler-Buggy, S; Birtwistle, J; ElMokhallalati, Y; Kindl, K; Good, P; Bennett, MI |
| 2022-06-14 | Research agenda for medical cannabis in palliative care. | Gurgenci, T; Hardy, J; Good, P |
| 2012-11-01 | Specialists' experiences and perspectives on the timing of referral to palliative care: A qualitative study | Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2022-01-01 | Survival following palliative percutaneous nephrostomy tube insertion in patients with malignant ureteric obstruction: Validating a prognostic model | Gunawan, B; Foster, K; Hardy, J; Good, P |
| 2019-02-20 | Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults | Haywood, A; Duc, J; Good, P; Khan, S; Rickett, K; Vayne-Bossert, P; Hardy, JR |
| 2024-02-10 | The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life. | Haupt, LM; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Pharasi, A; Zunk, M; George, R; Griffiths, LR; Good, P; Hardy, J |
| 2017-04 | The Liminal and the Parallax: Living and Dying at the End of Life. | MacArtney, JI; Broom, A; Kirby, E; Good, P; Wootton, J |
